Literature DB >> 11127212

Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin.

H Luukinen1, S M Käkönen, K Pettersson, K Koski, P Laippala, T Lövgren, S L Kivelä, H K Väänänen.   

Abstract

We examined serum total osteocalcin (TOC), carboxylated osteocalcin (COC), and their ratio (COC/TOC) by one-step two-site immunofluorescent assays in 87% (n = 792) of all home-dwelling persons of 70 years or older living in a defined area in northern Finland. Other baseline subject-related risk factors of fractures were assessed by postal questionnaires, interviews, clinical examinations, and tests. During a 5-year follow-up period, all falls and fractures (n = 106) were recorded by regular phone calls and by examining all the medical records yearly. Serum TOC and COC concentrations increased with advancing age and were higher in women than in men, but corresponding differences were not found in the case of COC/TOC. The adjusted relative risk of fracture was elevated in association with low (< or =-1 SD from the mean) COC; hazard ratio (HR, 95% CI) 2.00 (1.20-3.36) and low COC/TOC; HR 5.32 (3.26-8.68), the relative risk being highest in the population older than 80 years; and HR 7.02 (2.42-20.39). The predictive value of low COC/TOC lasted 3 years. The multivariable-adjusted relative risk of hip fracture (n = 26) in regard to low COC/TOC ratio was 3.49 (1.12-10.86), as compared with the persons who did not suffer hip fractures. Our results suggest that serum COC concentrations and, more strongly, COC/TOC, predict the occurrence of fractures in older community-dwelling adults. The risk of fracture associated with low COC/TOC equals the hip fracture risk previously verified for concomitant high serum undercarboxylated OC concentrations and low bone mineral density.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11127212     DOI: 10.1359/jbmr.2000.15.12.2473

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  44 in total

1.  Low serum vitamin D is associated with increased mortality in elderly men: MrOS Sweden.

Authors:  H Johansson; A Odén; J Kanis; E McCloskey; M Lorentzon; Ö Ljunggren; M K Karlsson; P M Thorsby; Å Tivesten; E Barrett-Connor; C Ohlsson; D Mellström
Journal:  Osteoporos Int       Date:  2011-10-19       Impact factor: 4.507

2.  Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study.

Authors:  M Iki; A Morita; Y Ikeda; Y Sato; T Akiba; T Matsumoto; H Nishino; S Kagamimori; Y Kagawa; H Yoneshima
Journal:  Osteoporos Int       Date:  2006-05-03       Impact factor: 4.507

3.  Association of dietary and biochemical measures of vitamin K with quantitative ultrasound of the heel in men and women.

Authors:  R R McLean; S L Booth; D P Kiel; K E Broe; D R Gagnon; K L Tucker; L A Cupples; M T Hannan
Journal:  Osteoporos Int       Date:  2006-01-06       Impact factor: 4.507

4.  Vitamin D sufficiency is associated with low incidence of limb and vertebral fractures in community-dwelling elderly Japanese women: the Muramatsu Study.

Authors:  K Nakamura; T Saito; M Oyama; R Oshiki; R Kobayashi; T Nishiwaki; M Nashimoto; Y Tsuchiya
Journal:  Osteoporos Int       Date:  2010-03-24       Impact factor: 4.507

5.  Bone turnover markers are correlated with quantitative ultrasound of the calcaneus: 5-year longitudinal data.

Authors:  J Lenora; P Gerdhem; K J Obrant; K K Ivaska
Journal:  Osteoporos Int       Date:  2008-10-23       Impact factor: 4.507

6.  Influence of fall environment and fall direction on risk of injury among pre-frail and frail adults.

Authors:  S K Gratza; P O Chocano-Bedoya; E J Orav; M Fischbacher; G Freystätter; R Theiler; A Egli; R W Kressig; J A Kanis; H A Bischoff-Ferrari
Journal:  Osteoporos Int       Date:  2019-08-03       Impact factor: 4.507

7.  No effect of vitamin K1 intake on bone mineral density and fracture risk in perimenopausal women.

Authors:  L Rejnmark; P Vestergaard; P Charles; A P Hermann; C Brot; P Eiken; L Mosekilde
Journal:  Osteoporos Int       Date:  2006-05-09       Impact factor: 4.507

8.  Impact and risk factors of post-stroke bone fracture.

Authors:  Kang Huo; Syed I Hashim; Kimberley L Y Yong; Hua Su; Qiu-Min Qu
Journal:  World J Exp Med       Date:  2016-02-20

Review 9.  Efficacy of menatetrenone (vitamin K2) against non-vertebral and hip fractures in patients with neurological diseases: meta-analysis of three randomized, controlled trials.

Authors:  Jun Iwamoto; Hideo Matsumoto; Tsuyoshi Takeda
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

10.  Prior treatment with vitamin K(2) significantly improves the efficacy of risedronate.

Authors:  Y Matsumoto; Y Mikuni-Takagaki; Y Kozai; K Miyagawa; K Naruse; H Wakao; R Kawamata; I Kashima; T Sakurai
Journal:  Osteoporos Int       Date:  2009-03-12       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.